Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Because the rationale for MDT depends on the ablation of ... with the use of an androgen receptor pathway inhibitor, in managing castration sensitive metastatic prostate cancer,” Dr Dreicer ...

such as tamoxifen or aromatase inhibitors for breast cancer or androgen ablation for prostate cancer. The effects of chemotherapy-associated cardiovascular toxicity and alterations in ...

Conclusion: Local ablation can improve the therapeutic effect ... Myc-Cap is a cell line derived from a TRAMP transgenic prostate cancer mouse model, which expresses androgen receptors and is ...

However, therapeutic resistance to androgen receptor inhibition is almost universal. Prostate cancer cells can develop resistance to androgen ablation through an adaptive marked upregulation of ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer.